This is a market research, observational study to evaluate the tolerability and acceptability of MCT supplements for young children and young people with intractable epilepsy, GLUT-1 or PDHD from 3 years to adulthood. Patients with a confirmed diagnosis of a fatty acid oxidation disorder, which requires a specialist diet including MCT will be included in this study
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
12
Subjects will be asked to take 3 new MCT products for 7 days each over a 25 day period (21 days taking the new products with 2 days between each new product trialled).
Bristol Royal Hospital for Children
Bristol, United Kingdom
Royal Manchester Children's Hospital
Manchester, United Kingdom
Gastrointestinal tolerance
Questionnaire detailing any GI symptoms, severity and change from usual The collection of daily data about the gastrointestinal tolerance of the product
Time frame: 7 days for each product, maximum 25 days
Product compliance
Daily questionnaire on amounts offered and amounts actually consumed, compared to recommended amount.
Time frame: 7 days for each product, maximum 25 days
Product palatability
Questionnaire data captured to evaluate taste
Time frame: 7 days for each product, maximum 25 days
Product acceptability
Brief tick-box questionnaire on overall liking and acceptability of product
Time frame: 7 days for each product, maximum 25 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.